Friday, July 31, 2026

Bitcoin’s Market Cap Plummets: Is the 2 Trillion USD Barrier About to Break?

The global crypto market cap nears $2 trillion, driven by ETF outflows and liquidity concerns, erasing gains since Trump's election.

Why 80% of Companies Want to Reopen Kaesong Industrial Complex: A Deep Dive into the Benefits

Reopening the Kaesong Industrial Complex could enhance inter-Korean relations, with 80% of former companies eager to return.

From Corporate Battles to Fan Cheers: Min Hee Jin’s Triumph at Tokyo Dome!

Despite facing conflicts with the parent company...

Tag: SK Biopharmaceuticals

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

SK Biopharmaceuticals Launches U.S. Innovation Hub to Help Korean Biotechs Expand Globally

SK Biopharmaceuticals launched SK Life Science LinX to support Korean biotech firms entering the U.S. market, fostering innovation and collaboration.

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

SK Biopharmaceuticals Selects Two CNS Startups Through Open Innovation… Advances Expected in Parkinson’s and Alzheimer’s Treatment

SK Biopharmaceuticals partners with Seoul Bio Hub to support two CNS startups, Novorex and Threebrooks, in innovative drug development.

Exploring Cenobamate: How SK Biopharmaceuticals’ New Oral Suspension Benefits Adult Epilepsy Patients

SK Biopharmaceuticals submits NDA for Cenobamate oral suspension, enhancing treatment options for epilepsy patients with swallowing difficulties.

SK Biofarm, FDA Approved Radioactive Method: Will it be a Revolutionary Cancer Cure with SLK 33501?

SK Biopharmaceuticals gains FDA approval for Phase 1 trials of radiopharmaceuticals SKL35501 and SKL35502, advancing cancer treatment.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.